World's Best Scientists 2026 revealed!
Danuta M. Skowronski

Danuta M. Skowronski

D-Index & Metrics

Immunology

D-Index
62
Citations
18811
World Ranking
3102
National Ranking
74

Danuta M. Skowronski publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Danuta M. Skowronski sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 205 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Danuta M. Skowronski D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Danuta M. Skowronski sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Danuta M. Skowronski is affiliated with the University of British Columbia in Canada and has contributed extensively to the field of medicine, with a focus on infectious diseases and epidemiology. Their research primarily addresses respiratory viral infections, particularly SARS-CoV-2 and influenza viruses.

The scientist's work spans several interconnected topics including:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Influenza Virus Research Studies
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 detection and testing

Skowronski has published in key venues that repeatedly feature their research, such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Eurosurveillance
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases

Frequent co-authors include:

  • Gaston De Serres
  • Sara Carazo
  • Denis Talbot
  • Agatha N. Jassem
  • Nicholas Brousseau

Notable recent publications authored or co-authored by Skowronski demonstrate an emphasis on vaccine effectiveness and epidemiological assessments, including:

  • Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada (2022), Clinical Infectious Diseases
  • Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada (2022), Canadian Medical Association Journal
  • Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada (2021), bioRxiv (Cold Spring Harbor Laboratory)
  • 2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN) (2024), Eurosurveillance

Best Publications

  • The Genome Sequence of the SARS-associated Coronavirus

    Marco A. Marra;Steven J. M. Jones;Caroline R. Astell;Robert A. Holt

  • Identification of Severe Acute Respiratory Syndrome in Canada

    Susan M. Poutanen;Susan M. Poutanen;Donald E. Low;Bonnie Henry;Sandy Finkelstein

  • Network theory and SARS: predicting outbreak diversity.

    Lauren Ancel Meyers;Babak Pourbohloul;M. E.J. Newman;M. E.J. Newman;Danuta M. Skowronski

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

    Danuta M Skowronski;Gaston De Serres

  • Human illness from avian influenza H7N3, British Columbia.

    S. Aleina Tweed;Danuta M. Skowronski;Samara T. David;Andrew Larder

  • Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

    Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Suzana Sabaiduc

  • Epidemiology of pertussis.

    Tina Quanbee Tan;Evelinda Trindade;Danuta Skowronski

  • Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada

    Danuta M. Skowronski;Gaston De Serres;Natasha S. Crowcroft;Naveed Z. Janjua

  • Repeated annual influenza vaccination and vaccine effectiveness: review of evidence

    Edward A. Belongia;Danuta M. Skowronski;Huong Q. McLean;Catharine Chambers

  • The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials.

    G De Serres;D M Skowronski;X W Wu;C S Ambrose

  • Novel avian influenza H7N3 strain outbreak, British Columbia

    Martin Hirst;Caroline R Astell;Malachi Griffith;Shaun M. Coughlin

  • Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

    D.M. Skowronski;C. Masaro;T.L. Kwindt;A. Mak

  • The changing age and seasonal profile of pertussis in Canada

    Danuta M. Skowronski;Gaston De Serres;Diane MacDonald;Diane MacDonald;Wrency Wu

  • A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season

    Danuta M. Skowronski;Catharine Chambers;Suzana Sabaiduc;Gaston De Serres

  • Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

    Unknown

  • Rapid Decline of Influenza Vaccine—Induced Antibody in the Elderly: Is It Real, or Is It Relevant?

    Danuta M. Skowronski;S. Aleina Tweed;Gaston De Serres

  • Severe Acute Respiratory Syndrome (SARS): A Year in Review

    Danuta M. Skowronski;Caroline Astell;Robert C. Brunham;Donald E. Low

  • An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus

    David M Patrick;Martin Petric;Danuta M Skowronski;Roland Guasparini

  • Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015

    Danuta M. Skowronski;Catharine Chambers;Gaston De Serres;Suzana Sabaiduc

  • Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America.

    Babak Pourbohloul;Armando Ahued;Bahman Davoudi;Rafael Meza

  • Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.

    Raymond H. See;Alexander N. Zakhartchouk;Martin Petric;David J. Lawrence

Frequent Co-Authors

Gaston De Serres
Gaston De Serres Université Laval
Yan Li
Yan Li Public Health Agency of Canada
Martin Petric
Martin Petric University of British Columbia
Mel Krajden
Mel Krajden University of British Columbia
Hugues Charest
Hugues Charest University of Montreal
Nathalie Bastien
Nathalie Bastien Public Health Agency of Canada
Jonathan B. Gubbay
Jonathan B. Gubbay BC Children's Hospital Foundation
Robert C. Brunham
Robert C. Brunham University of British Columbia
Steven J. Drews
Steven J. Drews Canadian Blood Services
Guy Boivin
Guy Boivin Université Laval

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your education through complementary healthcare programs can open diverse career opportunities. Many students explore practical nursing as a stepping stone, and identifying lpn schools easy to get into can be a strategic way to begin a healthcare career with manageable admissions requirements.

Advancing further, becoming a Family Nurse Practitioner (FNP) offers a broader scope of practice. When selecting a program, it’s helpful to consider the easiest fnp program options to ensure timely and efficient progression toward certification.

For those drawn to mental health, Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs blend clinical expertise with psychological care. If clinical experience placement is vital, checking the best online pmhnp programs can guide candidates to reputable programs with strong practicum support.

Cost is another significant factor. Finding affordable educational paths like the cheapest psych np programs ensures you can pursue your goals without overwhelming financial burden.

Best Scientists Citing Danuta M. Skowronski

Trending Scientists

Recently Published Articles